Wugen is a clinical stage immuno-oncology cell therapy company, developing off-the-shelf NK and CAR-T cell therapies for the treatment of both solid tumor and heme malignancies.


Biotechnology

Wugen

Wugen's headquarters in St. Louis, MO, United States

Kumar Srinivasan

Ayman Kabakibi

Cherry T. Thomas

Matthew Cooper

Keith Vendola

John McKearn

Natalie Mount

Melissa Berrien-Elliott

Kevin Li

Drew Dennison

Todd Fehniger

Katharine Hsu

Jeffrey Miller,

Bali Muralidhar

Bosun Hau

Waseem Qasim

Peter Kiener

Mark Alles

The Research and Development Scientists at Wugen focus on innovating and refining immuno-oncology cell therapies, specifically off-the-shelf NK and CAR-T therapies. This team conducts cutting-edge research, designs and executes experiments, and develops processes to enhance the efficacy and safety of treatments for solid tumors and hematologic malignancies. Their collaborative efforts ensure the advancement of Wugen's product pipeline from concept to clinical application.

Research and Development Scientists

The Clinical and Regulatory Affairs team at Wugen is responsible for ensuring the safe and effective development of innovative immuno-oncology therapies. This team oversees clinical trial management, regulatory compliance, and pharmacovigilance, coordinating efforts to navigate the complexities of clinical development and regulatory submissions. By collaborating with various stakeholders, they ensure that the company meets all regulatory standards while advancing its promising cell therapy programs.

Clinical and Regulatory Affairs

The Leadership Team at Wugen is responsible for guiding the strategic direction and operational execution of the company’s clinical-stage immuno-oncology initiatives. This team, comprised of executives with expertise in research and development, clinical operations, and strategy, collaborates to drive innovation in developing off-the-shelf NK and CAR-T cell therapies, ensuring alignment with Wugen's mission to advance treatment options for solid tumors and hematologic malignancies.

Leadership Team

The Research and Development team at Wugen focuses on advancing innovative immuno-oncology therapies, specifically off-the-shelf NK and CAR-T cell treatments. This team, comprising experts in cell biology and oncology, conducts preclinical research to optimize therapeutic efficacy, investigates novel applications for their therapies, and collaborates on clinical trial designs to bring breakthrough cancer treatments to patients.

Research and Development

The Finance and Operations team at Wugen plays a crucial role in supporting the company's clinical development and operational efficiency. This team oversees financial planning, budgeting, and analysis to ensure optimal resource allocation, while also driving operational excellence to streamline processes across departments. Collaborating closely with leadership, they ensure that Wugen's strategic objectives are met while maintaining fiscal responsibility.

Finance and Operations

The Advisory Roles team at Wugen provides expert guidance and strategic insights to advance the development of its innovative immuno-oncology therapies. Comprised of seasoned professionals with diverse backgrounds in oncology, clinical research, and biotechnology, the team advises on clinical trial design, regulatory strategy, and market positioning to enhance therapeutic efficacy and improve patient outcomes. Their insights help ensure Wugen's therapies align with the latest scientific advancements and industry standards.

��

Wugen

Org chart

Board & advisors

Teams

Research and Development Scientists

Clinical and Regulatory Affairs

Leadership Team

Research and Development

Finance and Operations

Advisory Roles

Offices

��������

Wugen

Org chart

Board & advisors

Teams

Research and Development Scientists

Clinical and Regulatory Affairs

Leadership Team

Research and Development

Finance and Operations

Advisory Roles

Offices

Related companies

��